Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/SHIONOGI-CO-LTD-6493659/attualita/Shionogi-Co-Ltd-Avvio-di-uno-studio-clinico-di-Fase-3-a-dosi-aggiuntive-su-soggetti-giapponesi-45586705/?utm_source=whatsapp&utm_medium=social&utm_campaign=share